Lower Fracture Rates in Patients Treated with Radium-223, Abiraterone or Enzalutamide, When Given Concurrently with Bone Health Agents: A Real-World Analysis
- Resource Type
- Article
- Source
- In
Clinical Genitourinary Cancer October 2022 20(5):399-403 - Subject
- Language
- ISSN
- 1558-7673